HSBC Holdings
RMD icon

HSBC Holdings’s ResMed RMD Stock Holding History

HSBC Holdings’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-50,000
Closed -$2.69M – 2218
2015
Q4 		$2.69M Buy
+50,000
New +$2.82M 0.01% 1173
2015
Q3 		– Sell
-50,000
Closed -$2.82M – 2125
2015
Q2 		$2.82M Hold
50,000
– – 0.01% 986
2015
Q1 		$3.59M Buy
+50,000
New +$3.25M 0.01% 1023

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HSBC Holdings's RMD Position: Q2 2026 in Review

HSBC Holdings increased its ResMed (RMD) stake by 13% in Q2 2026, buying an estimated $8.71M and bringing the position to 355,518 shares worth $69.3M. The position accounts for 0.03% of the portfolio, ranked #462.

HSBC Holdings first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $106M in Q4 2020. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • HSBC Holdings held 355,518 shares of ResMed worth $69.3M as of Q2 2026.
  • HSBC Holdings bought 42,007 ResMed shares in Q2 2026, an estimated $8.71M.
  • ResMed made up 0.03% of HSBC Holdings's portfolio in Q2 2026, its #462 holding.
  • HSBC Holdings first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • HSBC Holdings's ResMed position peaked at $106M in Q4 2020.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.